文献速递妇科

良性妇科手术中止血剂使用的医师与医院层面差异

Physician and Hospital-level Variation in Hemostatic Agent Use in Benign Gynecologic Procedures.
PubMed 文献 · J Minim Invasive Gynecol · 2022-06-30

基于Vizient临床数据库的回顾性队列研究,纳入2015年10月至2019年12月184 070例良性妇科手术(子宫切除术、盆腔器官脱垂修复、抗尿失禁手术),止血剂使用率从2015年第四季度15.6%升至2019年第四季度19.2%(p<.001),医师和医院身份累计可预测84.9%的止血剂使用。

要点

  • 止血剂在子宫切除术中最常用(20.7%),抗尿失禁手术中最少(10.9%)。
  • 止血剂使用率从2015年第四季度15.6%升至2019年第四季度19.2%(p<.001)。
  • 医师和医院身份累计预测84.9%的止血剂使用,其中医师身份65.5%、医院身份19.4%。

核心结论

  • 止血剂使用的显著差异主要由医师和医院身份驱动,提示在这些良性妇科手术中止血剂使用可能更多取决于医师和医院层面因素而非患者层面因素。

研究设计与样本

  • 回顾性队列研究,数据来自Vizient临床数据库,纳入2015年10月至2019年12月三个队列的≥18岁女性患者,分别接受良性孤立性子宫切除术、盆腔器官脱垂修复或抗尿失禁手术,最终队列共184 070例次。

主要发现

  • 止血剂在子宫切除术中使用最频繁(20.7%),在抗尿失禁手术中最少(10.9%)。
  • 止血剂使用率从2015年第四季度15.6%上升至2019年第四季度19.2%(p<.001)。
  • 使用止血剂的例次费用高于未使用者(6271.10美元 vs 4572.00美元;p<.001)。
  • 包含所有变量的bootstrap森林模型显示,医师和医院身份累计可预测84.9%的止血剂使用,其中医师身份65.5%、医院身份19.4%。
  • 个体医师间止血剂使用存在显著差异,59.9%的医师从未使用止血剂;在使用止血剂的医师中,72.8%的使用频率高于提供者平均使用率19.4%,9.2%的医师在其每例手术中均使用止血剂。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY OBJECTIVE: To identify recent nationwide trends in hemostatic agent (HA) use and to explore factors associated with HA use in 3 benign gynecologic surgery contexts: isolated hysterectomy, pelvic organ prolapse repair, and anti-incontinence surgery. DESIGN: Retrospective cohort study. SETTING: Vizient Clinical Database. PATIENTS: Three cohorts of female patients of ≥18 years who underwent benign isolated hysterectomy, pelvic organ prolapse repair, or anti-incontinence procedures were identified between October 2015 and December 2019. INTERVENTIONS: HAs are topically applied procoagulant products used for surgical hemostasis and use during included encounters was determined by charge codes. MEASUREMENTS AND MAIN RESULTS: Subject-, hospital-, and surgeon-level characteristics and costs were captured. Data were initially analyzed in the aggregate and based on procedure category using the chi-square test or independent samples t tests as appropriate. A bootstrap forest model was used to identify the factors most predictive of HA use. In the final cohort of 184 070 encounters, HAs were used most frequently in hysterectomy (20.7%) and least in anti-incontinence surgery (10.9%). The use of HAs increased from 15.6% in quarter 4 2015 to 19.2% in quarter 4 2019 (p <.001). Encounters using HAs cost more than encounters without HAs ($6271.10 vs $4572.00; p <.001). A bootstrap forest model inclusive of all variables found surgeon and hospital identity cumulatively predictive of 84.9% of HA use, 65.5% and 19.4%, respectively. There was significant variation in HA use among individual surgeons, with 59.9% never using HAs. Of those who did use HAs, 72.8% used HAs more frequently than the mean provider HA use rate (19.4%) and 9.2% used HAs in every case he/she performed. CONCLUSION: The significant variation in HA use is driven primarily by physician and hospital identity, suggesting that use of HA in these benign gynecologic surgical contexts may be determined more by physician- and hospital-level factors than patient-level factors.

来源:J Minim Invasive Gynecol,查看原文。版权归原作者所有。

引用

  1. Stachowicz AM, Lambert JW, Hohmann SF, et al. Physician and Hospital-level Variation in Hemostatic Agent Use in Benign Gynecologic Procedures. J Minim Invasive Gynecol. 2022. PMID: 35781055. doi:10.1016/j.jmig.2022.06.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。